Donald Trump's presidency could cause volatility for Indian sectors facing tariffs, but long-term geopolitical positioning favors India. Mixed Q3 earnings are expected, with IT and Pharma likely performing well. Lower large-cap valuations and targeted fiscal measures could boost the economy, focusing on consumption and investment continuity.
